Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/181697
Title: NcRNAs in Therapeutics: Challenges and Limitations in Nucleic Acid-Based Drug Delivery
Author: Hueso Val, Miguel
Mallén, Adrián
Suñé Pou, Marc
Aran Perramon, Josep M.
Suñé i Negre, Josep M. (Josep Maria)
Navarro, Estanis
Keywords: Nanomedicina
Àcids nucleics
Nanomedicine
Nucleic acids
Issue Date: 27-Oct-2021
Publisher: MDPI AG
Abstract: Non-coding RNAs (ncRNAs) are emerging therapeutic tools but there are barriers to their translation to clinical practice. Key issues concern the specificity of the targets, the delivery of the molecules, and their stability, while avoiding "on-target" and "off-target" side effects. In this "ncRNA in therapeutics" issue, we collect several studies of the differential expression of ncRNAs in cardiovascular diseases, bone metabolism-related disorders, neurology, and oncology, and their potential to be used as biomarkers or therapeutic targets. Moreover, we review recent advances in the use of antisense ncRNAs in targeted therapies with a particular emphasis on their basic biological mechanisms, their translational potential, and future trends.
Note: Reproducció del document publicat a: https://doi.org/10.3390/ijms222111596
It is part of: International Journal of Molecular Sciences, 2021, vol. 22, num. 21, p. 11596
URI: http://hdl.handle.net/2445/181697
Related resource: https://doi.org/10.3390/ijms222111596
ISSN: 1422-0067
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
ijms-22-11596-v2.pdf6.68 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons